Earlier I shared the documentary Died Suddenly, about the skyrocketing cases of sudden death syndrome, attributed to the deadly affects of the vaccines, and the alarming evidence that coroners and embalmers are finding afterward.
However, the credibility of the documentary (particularly of the producer) is being debated online, and so I added an update to that post, linking to an article that appears to knowledgeably segregate the documentary’s factual data—which is important for people to know and share—from what may be inaccurate or sensationalized, thereby enabling readers to consider both sources and decide for themselves what to believe.
But then I came across the following podcast from UK Column entitled Toxic By Design: Big Pharma Experts Speak Out, wherein pharmaceutical experts, rather than focusing on the deadly affects of the vaccines, instead describe the actual production methods that were used, which did not follow any of the established industry standards. They’re claiming that the vaccines were able to bypass all of the clinical trials, safety regulations, production standards, administration protocols, etc. because they were not developed under the authority of health departments and industry regulators, but under the authority of the Department of Defense. So, falling under military jurisdiction, how they were developed and what is in them were kept secret, just like—as much as I hate to say it—a bio-weapon.
But to be clear: just as I expressed my skepticism regarding a sinister plot toward global depopulation in my prior post (as it simply makes no sense), I am also skeptical that the DOD would be intentionally killing US citizens with the vaccines (including their own military personnel), as well as billions of people around the world, as part of some sort of nefarious agenda (again, it makes no sense). My speculation is more toward the profit motive (as are all government actions): the billions that the military/industrial/pharmaceutical complex is raking in, with very little expense and zero liability, as all production/safety requirements (and liabilities) were waved under the guise of “public health emergency”, the declaration of which then triggers the legislation and infrastructure that was already in place.
According to data analyst Alexandra Latypova in the video, those enabling pieces already in place include:
Emergency Use Authorization, which allows the FDA to market a drug without any testing or data, under the condition that “no adequate, approved, and available alternatives” exist (which explains why such optional treatments were suppressed and even outright banned). From the FDA website:
The Emergency Use Authorization (EUA) authority allows FDA to help strengthen the nation’s public health protections against chemical, biological, radiological, and nuclear (CBRN) threats including infectious diseases, by facilitating the availability and use of medical countermeasures (MCMs) needed during public health emergencies.
Under section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), when the Secretary of HHS declares that an emergency use authorization is appropriate, FDA may authorize unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions caused by CBRN threat agents when certain criteria are met, including there are no adequate, approved, and available alternatives. The HHS declaration to support such use must be based on one of four types of determinations of threats or potential threats by the Secretary of HHS, Homeland Security, or Defense.
PREP ACT absolves pharmaceutical companies (and all participants in the supply chain) from any liability. Again, from the FDA website:
The Public Readiness and Emergency Preparedness Act (PREP Act) authorizes the Secretary of the Department of Health and Human Services (Secretary) to issue a PREP Act declaration. The declaration provides immunity from liability (except for willful misconduct) for claims:
• of loss caused, arising out of, relating to, or resulting from administration or use of countermeasures to diseases, threats and conditions
• determined by the Secretary to constitute a present, or credible risk of a future public health emergency
• to entities and individuals involved in the development, manufacture, testing, distribution, administration, and use of such countermeasures
Other Transactional Authority or OTA allows the DOD to work with private manufacturers, described thusly:
There is no standard set of regulations or template for this award. The only defining characteristic would be the federal government’s identification of the award as an Other Transaction Authority or OTA. When we receive an OTA we must pay close attention to the terms and conditions in the agreement as they likely differ from what we are used to seeing in federal grants and contracts. Some agencies with the authority to use OTAs are NASA, the Department of Defense (DoD), Department of Health and Human Services (including NIH), and Department of Energy (DOE).
So according to the video, the “vaccines” were developed and administered under authority of the Department of Defense, in complete secrecy, with total immunity to any accountability or liability—no different, as Ms. Latypova points out, than would happen with a weapon.
Definitely worth a watch:
A Note To Readers:
If you found this article (or any of the others, for that matter) interesting, informative, entertaining, etc., please consider subscribing to the INSIGHTS email newsletter: simply enter your email into the form below (also in the right sidebar)—or, if you prefer, just use this simple quick sign-up form.
↓↓↓ Also, please hit the “Like” (thumbs up) button below. Thanks! ~ Rand